Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis

Tumor cells employ metabolic mechanisms to limit antitumor immunity and promote resistance to immunotherapy. However, how immunotherapy modulates tumor metabolism remains unclear. In this study, we demonstrated that anti-PD-1 treatment regulated cholesterol biosynthesis in cancer cells through the effector cytokine IFNγ. Mechanistically, IFNγ-induced IRF1 transcriptionally suppresses the expression of SREBF2, a master regulator of cholesterol synthesis. Reduced cholesterol content inhibited tumor growth and sensitized tumor cells to statins, drugs that can lower cholesterol. Overall, our study reveals that IFNγ-mediated inhibition of cholesterol biosynthesis in tumor cells is an important antitumor mechanism of immunotherapy.

Authors

Institutions

Publication Details

Journal
Cancer Immunology Research
Published
2025-12-09
DOI
https://doi.org/10.1158/2326-6066.cir-25-0242
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis

Wen Rui, Danyang Wang, Xiaojun Xia, Xiaomin Zhang et al.
Cancer Immunology Research
Cancer, Lipids, and Metabolism
article

Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis

Wen Rui, Danyang Wang, Xiaojun Xia, Xiaomin Zhang, Wende Li, Penghui Zhou, Changjun Gao, Shuangye Liao, Liping Xu, Jianeng Zhang, Ziqian Fang, Hongyuan Chen, Bo Li, Xiaoqing Wu, Juan Yang, Xiaowei Lai, M L Chang
article en

Abstract

Tumor cells employ metabolic mechanisms to limit antitumor immunity and promote resistance to immunotherapy. However, how immunotherapy modulates tumor metabolism remains unclear. In this study, we demonstrated that anti-PD-1 treatment regulated cholesterol biosynthesis in cancer cells through the effector cytokine IFNγ. Mechanistically, IFNγ-induced IRF1 transcriptionally suppresses the expression of SREBF2, a master regulator of cholesterol synthesis. Reduced cholesterol content inhibited tumor growth and sensitized tumor cells to statins, drugs that can lower cholesterol. Overall, our study reveals that IFNγ-mediated inhibition of cholesterol biosynthesis in tumor cells is an important antitumor mechanism of immunotherapy.

Cancer Immunology ResearchVol. 14(3)
Nanchang University (CN), Hunan University of Traditional Chinese Medicine (CN), Sun Yat-sen University (CN), Hunan University (CN), Guangdong Pharmaceutical University (CN), Hunan University of Science and Engineering (CN), Guangdong Laboratory Animals Monitoring Institute (CN), Sun Yat-sen University Cancer Center (CN), State Key Laboratory of Oncology in South China, Southern Medical University (CN)
Openalex Percentile: Top 52%
Cancer, Lipids, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.